[1] Crivellato E, Beltrami C, Mallardi F, et al. Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells. Br J Haematol,2003,123:19-21.
[2] Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med,2012,18:693-704.
[3] Katsoulis-Dimitriou K, Kotrba J, Voss M, et al. Mast Cell Functions Linking Innate Sensing to Adaptive Immunity. Cells,2020, 9(12):2538.
[4] Mendez-Enriquez E, Hallgren J. Mast Cells and Their Progenitors in Allergic Asthma. Front Immunol,2019,10:821.
[5] Mo R, Lai R, Lu J, et al. Enhanced autophagy contributes to protective effects of IL-22 against acetaminophen-induced liver injury. Theranostics,2018,8:4170-4180.
[6] Mendoza RP, Fudge DH, Brown JM. Cellular Energetics of Mast Cell Development and Activation. Cells,2021, 10(3):524.
[7] Grootens J, Ungerstedt JS, Nilsson G, et al. Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells. Blood Adv,2018,2:2273-2281.
[8] Chen CC, Grimbaldeston MA, Tsai M, et al. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci U S A,2005,102:11408-11413.
[9] Galli SJ, Grimbaldeston M, Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol,2008,8:478-486.
[10] Jarido V, Kennedy L, Hargrove L, et al. The emerging role of mast cells in liver disease. Am J Physiol Gastrointest Liver Physiol,2017,313:G89-G101.
[11] Pham L, Kennedy L, Baiocchi L, et al. Mast cells in liver disease progression: An update on current studies and implications. Hepatology,2022,75:213-218.
[12] Koruk ST, Ozardali I, Dincoglu D, et al. Increased liver mast cells in patients with chronic hepatitis C. Indian J Pathol Microbiol,2011,54:736-740.
[13] Li H, Zhao LF, Hao YQ, et al. Changes in mast cells and hepatic expression of c-kit and stem cell factor in the rat model of chronic hepatitis. Zhonghua Gan Zang Bing Za Zhi,2013,21:869-873.
[14] Terada T, Matsunaga Y. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol,2000,33:961-966.
[15] Grizzi F, Franceschini B, Chiriva-Internati M, et al. Mast cells and human hepatocellular carcinoma. World J Gastroenterol,2003,9:1469-1473.
[16] Tu JF, Pan HY, Ying XH, et al. Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma. Medicine (Baltimore), 2016,95:e3220.
[17] Choudhary NS, Saigal S, Bansal RK, et al. Acute and Chronic Rejection After Liver Transplantation: What A Clinician Needs to Know. J Clin Exp Hepatol,2017,7:358-366.
[18] Arikan C, Nart D, Kilic M, et al. Association of mast cells and liver allograft rejection. Pediatr Transplant,2008,12:347-352.
[19] Nakano T, Lai CY, Goto S, et al. Immunological and regenerative aspects of hepatic mast cells in liver allograft rejection and tolerance. PLoS One,2012,7:e37202.
[20] Masubuchi S, Takai S, Jin D, et al. Chymase inhibitor ameliorates hepatic steatosis and fibrosis on established non-alcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet. Hepatol Res,2013,43:970-978.
[21] Kennedy L, Meadows V, Sybenga A, et al. Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet. Hepatology,2021,74:164-182.
[22] Elieh Ali Komi D, Ribatti D. Mast cell-mediated mechanistic pathways in organ transplantation. Eur J Pharmacol,2019,857:172458.
[23] Zhao YB, Yang SH, Shen J, et al. Interaction between regulatory T cells and mast cells via IL-9 and TGF-beta production. Oncol Lett,2020,20:360.
[24] Kambayashi T, Allenspach EJ, Chang JT, et al. Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. J Immunol,2009,182:4686-4695.
[25] Frossi B, D'Inca F, Crivellato E, et al. Single-cell dynamics of mast cell-CD4+ CD25+ regulatory T cell interactions. Eur J Immunol,2011,41:1872-1882.
[26] Yasuda K, Nakanishi K, Tsutsui H. Interleukin-18 in Health and Disease. Int J Mol Sci,2019,20.
[27] Wang YY, Dahle MK, Agren J, et al. Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation. Shock,2006,25:141-146.
[28] Gauchat JF, Henchoz S, Mazzei G, et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature,1993,365:340-343.
[29] Hong GU, Lim JY, Kim NG, et al. IgE and IgA produced by OX40-OX40L or CD40-CD40L interaction in B cells-mast cells re-activate FcepsilonRI or FcalphaRI on mast cells in mouse allergic asthma. Eur J Pharmacol,2015,754:199-210. |
